Our Pricing

Buy Mounjaro Single Pen - KwikPen Needles Available

When you buy Mounjaro single pen UK online from Cured Pharmacy, you receive genuine tirzepatide KwikPen units from £135.00 complete with guidance on compatible needle options. Our UK-registered clinical team provides free online consultations, transparent upfront pricing, and discreet next-day delivery across the United Kingdom.

Understanding the Mounjaro KwikPen System

The Mounjaro KwikPen is a pre-filled, single-patient-use injection device containing tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults [1]. Each pen delivers four weekly doses at a fixed concentration, eliminating the need for manual dose measurement or vial handling.

Tirzepatide works by activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing superior weight reduction compared to single-pathway treatments [1]. This dual mechanism enhances insulin secretion, slows gastric emptying, and reduces appetite through central nervous system pathways.

In the SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks, with 63% of patients losing at least 20% of their initial body weight [2]. These outcomes represent the highest efficacy demonstrated in any obesity pharmacotherapy trial to date.

KwikPen Needle Compatibility and Selection

The Mounjaro KwikPen requires separate injection needles, which are not included with the pen device. Compatible needles include BD AutoShield Duo, BD Ultra-Fine, and other standard pen needles with universal thread design meeting ISO 11608-2 specifications.

Most patients find 4mm or 5mm needle lengths appropriate for subcutaneous injection into the abdomen, thigh, or upper arm. Needle gauge typically ranges from 31G to 32G, with finer gauges (higher numbers) producing less injection discomfort. Your prescriber will provide specific guidance based on your body composition and injection site preferences.

At Cured Pharmacy, our clinical team includes needle selection guidance with every Mounjaro prescription. We recommend discussing needle length and gauge during your consultation to ensure optimal comfort and proper subcutaneous delivery.

Proper Injection Technique

Attach a new sterile needle before each injection, rotating injection sites weekly to minimise lipodystrophy risk. The KwikPen's dose button clicks audibly when activated, and you should maintain pressure for 5-10 seconds after the dose counter returns to zero to ensure complete delivery [3].

Never share pens or needles between patients, even if the needle is changed. Each KwikPen contains enough medication for four weekly injections at the prescribed dose, after which the entire pen should be safely disposed of in a sharps container.

Mounjaro Dosing Schedule and Titration

Treatment begins with a 2.5mg once-weekly dose for four weeks, serving as a tolerability phase rather than a therapeutic dose. Your prescriber will then increase the dose to 5mg weekly, with potential escalation to 7.5mg, 10mg, 12.5mg, or 15mg based on your weight loss response and side effect profile [1].

Dose escalation typically occurs at four-week intervals, allowing your gastrointestinal system to adapt and minimising common side effects such as nausea and diarrhoea. The SURMOUNT trials demonstrated that gradual titration significantly improved treatment adherence compared to rapid dose increases [2].

Each Mounjaro single pen delivers four doses at one strength. As you progress through higher dose tiers, you'll receive new pens calibrated to your current prescription strength. This system ensures dosing accuracy and eliminates the risk of administration errors.

When to Escalate or Maintain Dose

Your UK prescriber will assess weight loss progress, tolerability, and metabolic markers before recommending dose escalation. Most patients reach their maintenance dose between 10mg and 15mg weekly, though some achieve their goals at lower doses [2].

If you experience persistent gastrointestinal side effects, your prescriber may extend the current dose phase by an additional four weeks before escalating. This individualised approach optimises both efficacy and treatment adherence.

Clinical Efficacy: What the Evidence Shows

The SURMOUNT clinical trial programme enrolled over 5,000 adults with obesity or overweight with weight-related comorbidities. Participants receiving tirzepatide 15mg achieved mean weight reductions of 22.5% at 72 weeks, compared to 2.4% in the placebo group [2].

Importantly, 91% of patients on the highest dose achieved at least 5% weight loss (the threshold for clinically meaningful benefit), whilst 63% achieved at least 20% reduction — outcomes previously only observed with bariatric surgery [2]. These results were consistent across age, gender, and baseline BMI subgroups.

Beyond weight reduction, tirzepatide demonstrated significant improvements in cardiometabolic risk factors. Participants experienced average reductions in systolic blood pressure of 7-10 mmHg, HbA1c decreases of 0.5-0.9%, and improvements in liver fat content and inflammatory markers [1][2].

Common Side Effects and Management Strategies

Gastrointestinal side effects occur in approximately 60-80% of patients during initial titration, with nausea being most common (reported by 25-35% of participants in clinical trials) [2]. These effects typically peak during the first week after dose escalation and diminish over subsequent weeks as tachyphylaxis develops.

To minimise nausea and vomiting, eat smaller, more frequent meals, avoid high-fat foods, and stay well-hydrated. Taking your injection in the evening rather than morning may help some patients sleep through peak side effect periods. If symptoms persist beyond two weeks at a given dose, contact your prescriber to discuss management options.

Serious adverse events are rare but include potential thyroid C-cell tumours (observed in rodent studies), acute pancreatitis, gallbladder disease, and severe hypoglycaemia when combined with insulin or sulfonylureas [3]. Your prescriber will screen for contraindications including personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 before prescribing.

When to Seek Medical Attention

Contact your GP or prescriber immediately if you experience severe abdominal pain (potentially indicating pancreatitis), persistent vomiting leading to dehydration, visual changes, or signs of allergic reaction including facial swelling or difficulty breathing [3].

Regular monitoring appointments with your prescriber ensure early identification of complications and allow dose adjustments based on your individual response and tolerability profile.

Buy Mounjaro Single Pen Online: The Cured Pharmacy Process

Purchasing Mounjaro through Cured Pharmacy begins with a free online consultation completed in under three minutes. Our UK-registered prescribers review your medical history, current medications, weight loss goals, and contraindications to determine suitability for tirzepatide therapy.

If approved, your prescription is processed by our GPhC-registered pharmacy team (registration 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). We dispense only genuine UK-licensed medications sourced directly from licensed wholesalers, never grey-market imports.

Your Mounjaro single pen arrives in 100% discreet packaging via next-day delivery, with needle guidance included in your patient information leaflet. Prices start from £135.00 per pen, with transparent upfront pricing displayed before you complete your consultation — no hidden fees or surprise charges at checkout.

Ongoing prescriptions are managed through your patient account, where you can request repeat supplies, update medical information, or message our clinical team with questions. We provide continuous care throughout your weight loss journey, not just a one-time transaction.

Scientific References

1. Frias, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
2. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/14553

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine and is subject to availability and prescriber approval.